Submitted:
17 July 2025
Posted:
21 July 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Methods
2.1. Population
2.2. Image Analysis
2.3. Outcomes
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusion
Funding
Ethics Approval
Consent to Participate
Availability of Data and Material
Conflicts of Interest
References
- Sallustio, F.; Saia, V.; Marrama, F.; Pracucci, G.; Gandini, R.; Koch, G.; Mascolo, A.P.; D’Agostino, F.; Rocco, A.; Argiro’, R.; et al. Mechanical Thrombectomy for Acute Intracranial Carotid Occlusion with Patent Intracranial Arteries : The Italian Registry of Endovascular Treatment in Acute Stroke. Clin Neuroradiol 2021, 31, 21–29. [Google Scholar] [CrossRef] [PubMed]
- Hendrikse, J.; Hartkamp, M.J.; Hillen, B.; Mali, W.P.; van der Grond, J. Collateral Ability of the Circle of Willis in Patients with Unilateral Internal Carotid Artery Occlusion: Border Zone Infarcts and Clinical Symptoms. Stroke 2001, 32, 2768–2773. [Google Scholar] [CrossRef] [PubMed]
- Majoie, C.B.; Cavalcante, F.; Gralla, J.; Yang, P.; Kaesmacher, J.; Treurniet, K.M.; Kappelhof, M.; Yan, B.; Suzuki, K.; Zhang, Y.; et al. Value of Intravenous Thrombolysis in Endovascular Treatment for Large-Vessel Anterior Circulation Stroke: Individual Participant Data Meta-Analysis of Six Randomised Trials. Lancet 2023, 402, 965–974. [Google Scholar] [CrossRef] [PubMed]
- Raha, O.; Hall, C.; Malik, A.; D’Anna, L.; Lobotesis, K.; Kwan, J.; Banerjee, S. Advances in Mechanical Thrombectomy for Acute Ischaemic Stroke. BMJ Medicine 2023, 2. [Google Scholar] [CrossRef] [PubMed]
- Boulenoir, N.; Turc, G.; Ter Schiphorst, A.; Heldner, M.R.; Strambo, D.; Laksiri, N.; Girard Buttaz, I.; Papassin, J.; Sibon, I.; Chausson, N.; et al. Should Patients With Acute Minor Ischemic Stroke With Isolated Internal Carotid Artery Occlusion Be Thrombolysed? Stroke 2022, 53, 3304–3312. [Google Scholar] [CrossRef] [PubMed]
- Vagal, A.; Wintermark, M.; Nael, K.; Bivard, A.; Parsons, M.; Grossman, A.W.; Khatri, P. Automated CT Perfusion Imaging for Acute Ischemic Stroke: Pearls and Pitfalls for Real-World Use. Neurology 2019, 93, 888–898. [Google Scholar] [CrossRef] [PubMed]
- Mallon, D.; Fallon, M.; Blana, E.; McNamara, C.; Menon, A.; Ip, C.L.; Garnham, J.; Yousry, T.; Cowley, P.; Simister, R.; et al. Real-World Evaluation of Brainomix e-Stroke Software. Stroke Vasc Neurol 2023, svn. [Google Scholar] [CrossRef] [PubMed]
- Albers, G.W.; Marks, M.P.; Kemp, S.; Christensen, S.; Tsai, J.P.; Ortega-Gutierrez, S.; McTaggart, R.A.; Torbey, M.T.; Kim-Tenser, M.; Leslie-Mazwi, T.; et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med 2018, 378, 708–718. [Google Scholar] [CrossRef] [PubMed]
- Hoving, J.W.; Kappelhof, M.; Schembri, M.; Emmer, B.J.; Berkhemer, O.A.; Groot, A.E.D.; Dippel, D.W.J.; van Zwam, W.H.; Coutinho, J.M.; Marquering, H.A.; et al. Thrombectomy for Acute Ischemic Stroke Patients with Isolated Distal Internal Carotid Artery Occlusion: A Retrospective Observational Study. Neuroradiology 2021, 63, 777–786. [Google Scholar] [CrossRef] [PubMed]
- Meyer, L.; Broocks, G.; Alexandrou, M.; Lüttich, Á.; Larrea, J.Á.; Schwindt, W.; Krähling, H.; Naziri, W.; Behme, D.; Thormann, M.; et al. Endovascular versus Best Medical Treatment for Acute Carotid Occlusion BelOw Circle of Willis (ACOBOW): The ACOBOW Study. Radiology 2025, 314, e240293. [Google Scholar] [CrossRef] [PubMed]
- von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbroucke, J.P. ; STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Lancet 2007, 370, 1453–1457. [Google Scholar] [CrossRef] [PubMed]
- Kaiser, D.P.O.; Reiff, T.; Mansmann, U.; Schoene, D.; Strambo, D.; Michel, P.; Abdalkader, M.; Nguyen, T.N.; Gawlitza, M.; Möhlenbruch, M.A.; et al. Endovascular Treatment for Acute Isolated Internal Carotid Artery Occlusion. Clin Neuroradiol 2024, 34, 125–133. [Google Scholar] [CrossRef] [PubMed]
- Romoli, M.; Mosconi, M.G.; Pierini, P.; Alberti, A.; Venti, M.; Caso, V.; Vidale, S.; Lotti, E.M.; Longoni, M.; Calabresi, P.; et al. Reperfusion Strategies in Stroke Due to Isolated Cervical Internal Carotid Artery Occlusion: Systematic Review and Treatment Comparison. Neurol Sci 2021, 42, 2301–2308. [Google Scholar] [CrossRef] [PubMed]
- Marto, J.P.; Riegler, C.; Gebert, P.; Reiff, T.; Sykora, M.; Wiącek, M.; Pakizer, D.; Araújo, A.; Ter Schiphorst, A.; Sousa, J.A.; et al. Endovascular Treatment for Isolated Cervical Internal Carotid Artery Occlusion: ETIICA Study. Eur Stroke J 2025, 23969873251323488. [Google Scholar] [CrossRef] [PubMed]
- Ter Schiphorst, A.; Gaillard, N.; Dargazanli, C.; Mourand, I.; Corti, L.; Charif, M.; Ayrignac, X.; Lippi, A.; Bouly, S.; Thibault, L.; et al. Symptomatic Isolated Internal Carotid Artery Occlusion with Initial Medical Management: A Monocentric Cohort. J Neurol 2021, 268, 346–355. [Google Scholar] [CrossRef] [PubMed]
- Turc, G.; Bhogal, P.; Fischer, U.; Khatri, P.; Lobotesis, K.; Mazighi, M.; Schellinger, P.D.; Toni, D.; de Vries, J.; White, P.; et al. European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE). European Stroke Journal 2019, 4, 6–12. [Google Scholar] [CrossRef] [PubMed]

| Characteristics | EVT group(17 subjects) | BMT group(8 subjects) | P value | |
|---|---|---|---|---|
| Age (mean; SD) | 62.6 ± 13.6 | 69.2 ± 13.9 | n.s. | |
| Sex (M/F) | 14/3 | 7/1 | n.s. | |
| Diabetes (n) | 7 | 2 | n.s. | |
| Dyslipidemia (n) | 11 | 6 | n.s. | |
| High blood pressure (n) | 13 | 6 | n.s. | |
| Ischemic cardiomyopathy (n) | 2 | 2 | n.s. | |
| Hearth disease (n) | 6 | 3 | n.s. | |
| Carotid artery disease (n) | 12 | 6 | n.s. | |
| Chronic Obstructive Pulmonary Disease (n) | 1 | 0 | n.s. | |
| Previous ischemic stroke (n) | 2 | 0 | n.s. | |
| Atrial fibrillation (n) | 4 | 1 | n.s. | |
| Cigarette smoke (n) | 3 | 1 | n.s. | |
| Antiplatelet therapy at onset (n) | 7 | 5 | n.s. | |
| Anticoagulant therapy at onset (n) | 1 | 1 | n.s. | |
| Lipid-lowering therapy at onset (n) | 5 | 5 | n.s. | |
| NIHSS hospital admission (mean; SD) | 14.1 ± 5.6 | 6.2 ± 4.8 | 0.0025 ** | |
| Penumbra volume at onset (mean; SD) | 193.8 ± 147.1 | 30.0 ± 23.0 | 0.018 ** | |
| Core volume at onset (mean; SD) | 7.9 ± 8.6 | 0.9 ± 1.6 | 0.0332** | |
| Thrombolysis (IVT) (n) | 6 | 3 | n.s. | |
| NIHSS hospital discharge (mean; SD) | 8.6 ± 7.8 | 2.9 ± 2.2 | 0.0547 n.s. | |
| mRS at hospital discharge (n) | 2.4 ± 2.1 | 1.4 ± 0.9 | n.s. | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).